Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
Share
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Deako. SKYX Platforms has closed the merger with Deako, Inc., which we first covered in our September 11th report. As we noted then, the merger enables SKYX to offer an...
10/15/2026
Health
Ocugen (OCGN) – Ocugen Completes Licensing Agreement For MENA Region
Licensing Agreement Finalizes Terms Announced In July. Ocugen and Roots Pharmaceuticals have finalized a licensing agreement for the commercialization of OCU400 in the Middle East and North Africa. The license...
10/15/2026
Industrials
AZZ (AZZ) – Record Results Reinforce Growth Outlook
FY 2027 Second Quarter Results Exceed Expectations. AZZ reported adjusted net income of $60.1 million, or $2.00 per diluted share, compared with $46.9 million, or $1.55 per share, in the...
10/14/2026
Health
Release – Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the execution of a licensing agreement with Roots Pharmaceutical, and...
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.
